Public Apology and Commitment to Rectification regarding counterfeit COAs issue

Public Apology and Commitment to Rectification regarding counterfeit COAs issue

To Our Respected Partners and All Concerned,

We, at Shandong Runxin Biotechnology Co., Ltd., value transparency, trust, and integrity in all our dealings. It is with a commitment to these values that we address a serious issue that has come to light, affecting partners include SOTALIX SUPPLEMENT, GRIMED, AUMETO, among others. Herein, we detail the nature of this issue, how it was uncovered, and our comprehensive actions to ensure it is resolved and prevented in the future.

Detailed Issue Overview:

We have discovered a grave issue with the Certificate of Analysis (COA) documents, which are essential for demonstrating product quality and safety. These documents, which our partners have used for their selling application for their product listings on Amazon, were recently found to be counterfeit. Amazon's re-validation process involved contacting the laboratories listed on the COAs, and since the documents were falsified, the labs could not confirm their validity. As a direct consequence, Amazon has suspended the selling privileges for these product listings, severely impacting our partners.

How the Problem Was Uncovered:

The issue surfaced when Amazon initiated a re-validation of previously submitted COAs by reaching out to the third-party laboratories for confirmation. This process revealed that the laboratories had no records of the tests. Our investigation revealed that a member of our team, who was tasked with overseeing the testing and acquisition of COAs from qualified third-party laboratories, had not been submitting our products for actual testing. Instead, she produced counterfeit COAs and appropriated the funds intended for testing for her own personal benefit.

Immediate Response and Long-term Measures:

Upon discovering the fraudulent actions of this employee, we terminated her employment and have taken steps to recover the funds. We understand, however, that the issue goes deeper than the actions of a single individual. In response, we are:

• Implementing stricter protocols for the submission and verification of COAs to ensure they are genuinely issued by reputable third-party laboratories.
• Enhancing our internal audit processes to safeguard against any future breaches of this nature.
• Establishing more robust communication channels with our partners for transparency and immediate query resolution.

Commitment to Our Partners:

We apologize deeply for the inconvenience and potential harm this has caused. To rectify this situation, we pledge to:

• Cover the costs for all necessary product re-testing by accredited third-party laboratories to ensure valid and accurate COAs are obtained.
• Provide support and assistance to mitigate any adverse impacts on your business, prioritizing your reputation and operational needs.
• Work closely with each affected partner to develop a personalized plan addressing specific concerns and ensuring a swift resolution to this matter.

We are profoundly sorry for the difficulties this situation has caused. Our priority now is to rebuild your trust and to demonstrate our dedication to the highest standards of quality and integrity.

For any further inquiries or to discuss how we can assist you further, please reach out to us directly.

Thank you for your understanding and for standing with us as we navigate this challenging time.

Sincerely,

Betty Liu

Sales Manager,

Shandong Runxin Biotechnology Co., Ltd.